Sutharsan Govindarajan
Also known as: Sutharsan
SRM University, Andhra Pradesh, Hebrew University of Jerusalem
0000-0002-4080-8501
About
Dr. Sutharsan Govindarajan is an Associate Professor in the Department of Biological Sciences at SRM University-AP, India. His research focuses on the fundamental biology of bacteriophages and bacterial pathogens, with an emphasis on developing precision therapeutics for drug-resistant bacterial infections using bacteriophages, CRISPR-Cas technologies, and microbial genomics. His laboratory integrates fundamental phage biology with translational research and has contributed to personalised bacteriophage therapy for patients with otherwise difficult-to-treat drug-resistant infections.
Dr. Govindarajan earned his M.Sc. from Madurai Kamaraj University in 2010 and completed his Ph.D. at the Hebrew University of Jerusalem, Israel, in 2017. He subsequently pursued postdoctoral research at the University of California, San Francisco (UCSF), in the laboratory of Dr. Joseph Bondy-Denomy. In 2019, he returned to India and joined SRM University-AP as a faculty member.
He has received several prestigious awards, including the DBT-Wellcome Trust Early Career Award, DST-INSPIRE Faculty Award, H.P. Tiwari Best Faculty Award, and the Excellence in Ph.D. Award (2017) for the best doctoral thesis. He has secured seven competitive research grants totalling approximately ₹5 crore, including funding from DBT-Wellcome Trust, SreePVF - Translational Biomedical Award, DST-SERB, DBT, CEFIPRA, DST-INSPIRE, and the MeitY GENESIS programme.
Two Ph.D. students have completed their doctoral studies under his guidance. His laboratory currently comprises several Ph.D. students and a postdoctoral researcher working across bacteriophage biology, antimicrobial resistance, microbial genomics, CRISPR-based technologies, and translational phage therapy.
Employment
-
SRM University, Andhra Pradesh Assistant Professor and DBT-Wellcome Trust Early Career Faculty2019 - Present
Education
-
Hebrew University of Jerusalem PhD2010 - 2017
Projects & Funding
Projects & funding information is unavailable.
Publications (33)
- Triarylphosphonium-conjugated Sn(iv)-porphyrins for antimicrobial photodynamic therapy: impact of substituents on lipophilicity, aggregation, and photoantibacterial activity Save
- Periplasmic proteostasis enables bacterial survival during MreB cytoskeletal disruption Save
- KilR of E. coli Rac prophage is a dual inhibitor of bacterial cell division and elongation machineries Save
- Characterization and genomic analysis of Sharanji: a jumbo bacteriophage of Escherichia coli. Save
- KilR of E. coli Rac prophage is a dual morphogenetic inhibitor of bacterial cell shape Save
- Novel bacteriophages effectively target multidrug-resistant clinical isolates of Klebsiella pneumoniae Save
- Relative fitness of wild-type and phage-resistant pyomelanogenic P. aeruginosa and effects of combinatorial therapy on resistant formation. Save
- Exploring pangenomic diversity and CRISPR-Cas evasion potential in jumbo phages: a comparative genomics study Save
- Probing the Molecular Interactions of A22 with Prokaryotic Actin MreB and Eukaryotic Actin: A Computational and Experimental Study. Save
- Formulation of Dual-Functional Nonionic Cetomacrogol Creams Incorporated with Bacteriophage and Human Platelet Lysate for Effective Targeting of MDR P. aeruginosa and Enhanced Wound Healing. Save